Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
about
Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approachesNuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotypeProteomic profiling of follicular and papillary thyroid tumorsExtracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models.Matrigel induces L-plastin expression and promotes L-plastin-dependent invasion in human cholangiocarcinoma cells.Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model.Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinomaComparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma.Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.Global secretome analysis identifies novel mediators of bone metastasis.Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers.A systems biology approach for understanding the collagen regulatory network in alcoholic liver disease.Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinomaComparative protein profiles of Butea superba tubers under seasonal changes.SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.Shotgun proteomics of human bile in hilar cholangiocarcinoma.Disruption of endocytic trafficking protein Rab7 impairs invasiveness of cholangiocarcinoma cells.GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer.Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic ReviewModification of proteins secreted by endothelial cells during modeled low gravity exposureEmergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer TypeEffect of Derris scandens extract on a human hepatocellular carcinoma cell line
P2860
Q26821926-953CA398-CBAD-462F-966F-18F17891214EQ27305074-CD4AF40E-5601-4CC9-97CE-360C19011FD1Q28258081-F5F97642-25B5-40CE-9EFA-D67943B65186Q33952003-67C218F8-1F66-4545-B036-CF65FE12444FQ33967755-B5DC638A-00C0-4553-82CF-E67492B5A8DBQ33977095-F36C60A3-3E4C-4EC5-B580-8E8B752B877CQ34254009-830C24BD-1D5C-4F4A-8A90-395B0E4209C5Q34464452-0F41EC68-AFEC-4942-94C2-0D6C5DD7CBCDQ35790450-FC6CACA9-7F7B-469B-A0C7-2DE6BD02734BQ36210409-F9DC7C1D-CA50-4177-830C-1D5836A6407FQ37828118-B00696FE-B392-433E-9043-616DF63FFA01Q37899945-CEDA27EF-389D-4DB6-9BA7-3D36E39ECD52Q38176402-E6E68EC4-FB02-4142-8F08-6F54CD1A7C09Q38272979-6274184A-F7E5-44BD-A4C7-57F3C6DCC0A2Q38452333-96A4E749-6FB2-4285-97AB-BA0A2708760DQ38865032-616771D4-B4A4-4BCE-88A8-68F06A6E3EA4Q39671092-40D78C94-2777-48A3-8132-CB9AE2C16572Q44226984-6047D4EA-0545-4FC5-B0C1-31DA362E00D3Q47746007-123F69E8-1EA0-4AA3-AA6D-63DA33DDEC2BQ49431252-FD18F0DC-93F9-4A6C-A93A-EB363E9B0EA3Q55003973-08524735-8BC4-4166-9BB0-010F6578F624Q56379222-6C897AFC-55A0-4FB9-8761-13C33F5B625FQ56987114-C4DC990D-76EA-434A-9A11-66591BA50CA2Q57111762-3DBCE6FD-4D12-45F4-82EC-E2534C57EEDFQ57173323-BA64AF3D-7E6C-4C4E-8789-10537B2F88B1
P2860
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
@ast
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
@en
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.
@nl
type
label
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
@ast
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
@en
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.
@nl
prefLabel
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
@ast
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
@en
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.
@nl
P2093
P2860
P4510
P356
P1476
Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes
@en
P2093
Chantragan Srisomsap
Daranee Chokchaichamnankit
Khajeelak Chiablaem
Pantipa Subhasitanont
Phannee Sawangareetrakul
Sopit Wongkham
Vaharabhongsa Bhudhisawasdi
P2860
P304
P356
10.1155/2010/437143
P577
2009-12-27T00:00:00Z